194928-64-8

Basic information

• Product Name: 5-[(1E)-3-({2-[2,4-dichloro(methyl)-3-({[2-methyl-4-(2-pyridinylmethoxy)-8-quinolinyl]oxy}methyl)anilino]-2-oxoethyl}amino)-3-oxo-1-propenyl]-2-pyridinecarboxylic acid
• Synonyms: 5-[(1E)-3-({2-[2,4-dichloro(methyl)-3-({[2-methyl-4-(2-pyridinylmethoxy)-8-quinolinyl]oxy}methyl)anilino]-2-oxoethyl}amino)-3-oxo-1-propenyl]-2-pyridinecarboxylic acid
• CAS NO: 194928-64-8
• Molecular Weight: 686.551
• Mol File: 194928-64-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 5-[(1E)-3-({2-[2,4-dichloro(methyl)-3-({[2-methyl-4-(2-pyridinylmethoxy)-8-quinolinyl]oxy}methyl)anilino]-2-oxoethyl}amino)-3-oxo-1-propenyl]-2-pyridinecarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-[(1E)-3-({2-[2,4-dichloro(methyl)-3-({[2-methyl-4-(2-pyridinylmethoxy)-8-quinolinyl]oxy}methyl)anilino]-2-oxoethyl}amino)-3-oxo-1-propenyl]-2-pyridinecarboxylic acid(194928-64-8)
• EPA Substance Registry System: 5-[(1E)-3-({2-[2,4-dichloro(methyl)-3-({[2-methyl-4-(2-pyridinylmethoxy)-8-quinolinyl]oxy}methyl)anilino]-2-oxoethyl}amino)-3-oxo-1-propenyl]-2-pyridinecarboxylic acid(194928-64-8)

Safety Data

• Hazardous Substances Data: 194928-64-8(Hazardous Substances Data)

Upstream product

• 28507-46-2 4-chloro-8-hydroxy-2-methylquinoline 
• 194928-61-5 N-[2,4-dichloro-3-({[2-methyl-4-(2-pyridinylmethoxy)-8-quinolinyl]oxy}methyl)phenyl]-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-methylacetamide 
• 194928-62-6 2-amino-N-(2,4-dichloro-3-(((2-methyl-4-(pyridin-2-ylmethoxy)quinolin-8-yl)oxy)methyl)phenyl)-N-methylacetamide 
• 194928-60-4 2-methyl-4-(pyridin-2-yl)methoxyquinolin-8-ol 
• 167837-48-1 N-(2,4-dichloro-3-(hydroxymethyl)phenyl)-2-(1,3-dioxoisoindolin-2-yl)-N-methylacetamide 
• 586-98-1 2-Hydroxymethylpyridine 
• 194928-63-7 5-[(1E)-3-({2-[2,4-dichloro(methyl)-3-({[2-methyl-4-(2-pyridinylmethoxy)-8-quinolinyl]oxy}methyl)anilino]-2-oxoethyl}amino)-3-oxo-1-propenyl]-2-pyridinecarboxylate 

Relevant articles and documents

Discovery of the first non-peptide full agonists for the human bradykinin B2 receptor incorporating 4-(2-picolyloxy)quinoline and 1-(2-picolyl)benzimidazole frameworks

In the course of our studies on non-peptide bradykinin (BK) B2 receptor ligands, it was suggested that the 4-substituent of the quinoline ring may play a critical role in determining binding affinities for human and guinea pig B2 rec